ΟΣΤΕΟΝΕΚΡΩΣΗ ΜΗΡΙΑΙΑΣ ΚΕΦΑΛΗΣ

FEMORAL HEAD OSTEONECROSIS

operative treatment with autologous mesenchymal stem cells

 

Γεώργιος Δ. Γκουδέλης
Hip X-ray, femoral head osteonecrosis bilaterally

Γεώργιος Δ. Γκουδέλης
Femoral head osteonecrosis

Γεώργιος Δ. Γκουδέλης
MRI.  Femoral head osteonecrosis bilaterally

Γεώργιος Δ. Γκουδέλης
Hip MRI, femoral head osteonecrosis bilaterally

Γεώργιος Δ. Γκουδέλης

The osteonecrosis or avascular necrosis of the femoral head is a pathological condition where the blood supply is stopped in this subchondral bone resulting in the death of osteocytes and precipitating the articular surface.

The phenomenon of ischemic femoral head substantially disrupts the normal structure of cancellous bone, which in turn loses its supporting ability and subsides creating permanent deformation of the joint and premature osteoarthritis.
The disease occurs in young patients aged 35-45 years with triple incidence in men compared to women.

The factors that have been associated with the disease are divided in traumatic and non-traumatic.

In traumatic factors are:

hip trauma
the foregoing surgery on it,
the sliding of the femoral epiphyseal head in childhood.

In non-trauma agents include:

chronic use of corticosteroids,
alcoholism,
diving,
systemic lupus erythematosus,
sickle cell anemia,
hyperlipidemia (high cholesterol),
the existence of thrombophilia (heterozygous or homozygous) disease which patients largely unaware that they have.

Many times there may be identification of the cause of the disease is called idiopathic osteonecrosis. The pathogenetic mechanism leading to the disruption of the blood supply in these cases is multifactorial.

Adequate blood supply to an anatomical region is essential for the viability and function in the majority of body tissues.

Without the provision of adequate blood hypoxia conditions generated in the cells, lack of nutrient supply to them, accumulation of metabolic products, thus stopping the biochemical signaling mechanism, ultimately affecting cellular homeostasis total area.

The interruption of blood supply may be because:

1. the direct injury of nutrients arteries of the femoral head,
2. the clots inside arteries,
3. extrinsic compression of blood vessels from swelling of the surrounding elements (increased presence of fatty or other cellular elements in the bone of the femoral head).

Clinically, the patient can report pain in the groin or in the internal – anterior surface of the femur. Rarely can the pain be reflected in the ipsilateral buttock or even the ipsilateral knee.

Symptoms usually worsen with fatigue and decreases with rest. Most often there is a limitation in the motion of the hip joint especially in internal rotation and abduction.

Routine laboratory blood tests shows no pathological evidence but further research may demonstrate thrombophilia or systemic lupus erythematosus.

MRI is the method of choice for clear diagnostic assessment of the disease. The simple radiological examination more often than not brings out the damage in the initial stages leading to underestimation of the clinical status of the patient.

OPERATIVE TREATMENT

Therapy

Modern treatments for osteonecrosis of the femoral head aim to halt joint subsidence, thereby preventing the early onset of osteoarthritis, which will lead to premature total hip arthroplasty.

The promotion of bone and vascular regeneration by the application of autologous precursor cells – stem cells – is the most modern therapeutic approach.

The somatic mesenchymal stem cell (stem cell), derived from various parts of the body (bone marrow, adipose tissue, peripheral blood), represents a highly promising candidate for its application in cell therapy in various diseases.

It is considered to play a critical role in maintaining the integrity of various tissues such as skin, bone and blood. It has the property of maintaining its mitotic capacity without significant loss of its specific biomolecular characteristics during laboratory culture and is capable of differentiating into multiple mesenchymal phenotypes, i.e. other cells such as osteocytes and chondrocytes.

From the moment the blood supply is affected, a local inflammation begins which produces extensive bone swelling in the femoral head, which further affects the blood supply.

Surgical decompression by removing part of the core of the femoral head bone is currently an indicated therapeutic approach in the early stages of the disease, i.e. before subsidence occurs.

At the site where the bone section was removed, we apply the cultured autologous mesenchymal cells (stem cells) through a carrier, which will soon differentiate into osteocytes, promoting the creation of a new vascular network, thus recreating to a large extent the normal structure of the femoral head, preventing its subsidence and the appearance of osteoarthritis at a young age.

The autologous stem cells are obtained from the patient’s bone marrow and alternatively from the peripheral blood, 3-5 weeks before the surgery. Then, in a special laboratory, their multiplication is carried out, reaching 10.5 +/- 0.8 million cells.

Gene therapy based on stem mesenchymal cells is an evolution of regenerative medicine. The release of growth factors TGF-beta (transforming growth factor), VEGF (vascular endothelial growth factor), FGF (fibroblast growth factor) and other factors promote the repair of the affected bone. The method is also applied to other diseases of the musculoskeletal system such as fracture pseudoarthrosis, bone defects, bone tumors and there is a constant expansion of the boundaries of its therapeutic potential.

 

Under fluoroscopy, the lesion is initially targeted with a needle (left image) and then a 10 mm hole is drilled to decompress the bone marrow.

 

Application of cultured autologous stem cells to the site of the lesion in the femoral head.

Επικοινωνία phone phone clinic
Γεώργιος Δ. Γκουδέλης
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.